Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-28 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +5,478 $2.14 $12K 5,478
2023-07-28 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,478 $18.00 $99K 0
2023-07-28 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −5,478 383,381
2023-07-17 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +4,522 $2.14 $10K 4,522
2023-07-17 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −4,522 $18.11 $82K 0
2023-07-17 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −4,522 388,859
2023-07-10 Dable Habib J Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +2,412 $1.74 $4K 3,703
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +7,871 $2.14 $17K 11,574
2023-07-06 Dake Benjamin T SEE REMARKS Sale 10b5-1 −10,283 $16.66 $171K 1,291
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −906 5,433
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,506 19,589
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,019 21,386
2023-07-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −6,852 157,609
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +650 $1.74 $1K 2,259
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +1,600 $2.14 $3K 3,859
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −2,031 $17.23 $35K 1,828
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −219 $17.87 $4K 1,609
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −450 18,708
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −200 12,088

Page 14 of 16 · 315 trades